Clinical Trial Update: A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial of ONCO-DOX in locally advanced hepatocellular carcinoma was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ONCO-DOX

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hepatocellular Carcinoma, Hepatoma | Phase 3 | Status: TERMINATED | Results posted: 2017-11-08